Exploring Analyst Estimates for Western Midstream (WES) Q2 Earnings, Beyond Revenue and EPS

Wall Street analysts anticipate Western Midstream (WES) to report Q2 EPS of $0.82, a 15.5% year-over-year decline, despite a projected 4% revenue increase to $941.48 million. The consensus EPS estimate has seen a 0.5% downward revision over the past 30 days, signaling a reevaluation of expectations. While some key throughput metrics for natural gas, crude oil, NGLs, and produced water assets are forecast to show increases, others, particularly crude/NGLs from equity investments, are expected to decline, offering a mixed operational outlook. Despite WES shares gaining 3.3% in the last month, the stock carries a Zacks Rank #4 (Sell), suggesting potential near-term underperformance.

Analysis

Western Midstream (WES) faces a mixed outlook ahead of its Q2 earnings report, characterized by divergent top and bottom-line expectations. Wall Street projects a 4% year-over-year revenue increase to $941.48 million, but anticipates a significant 15.5% decline in earnings per share to $0.82, suggesting a potential for margin compression. This negative sentiment is reinforced by a 0.5% downward revision to the consensus EPS estimate over the past 30 days, a trend often correlated with short-term stock underperformance. A deeper look at operational metrics reveals a nuanced picture: throughput is expected to grow in key areas such as the Delaware Basin for produced-water (to 1,207.88k bbl/day) and crude/NGLs (to 263.08k bbl/day). However, these gains are offset by a notable projected decline in crude/NGL throughput from equity investments, which is forecast to drop to 102.91k bbl/day from 130.00k in the prior year. Despite the stock gaining 3.3% over the past month, the official Zacks Rank #4 (Sell) indicates that analysts anticipate near-term headwinds.

Key Decisions for Investors

• Investors should exercise caution heading into the earnings release, as the forecasted 15.5% EPS decline despite revenue growth points to significant margin pressure.
• Monitor the detailed throughput metrics in the report, specifically looking for performance in the Delaware Basin to offset the expected weakness from equity investment assets, as this will be a key indicator of operational health.
• Consider the conflict between the stock's recent price appreciation and the negative analyst sentiment, evidenced by the Zacks Rank #4 (Sell) and downward EPS revisions, which may signal a risk of a post-earnings pullback.